1. Acute pancreatitis in a patient treated with imatinib and gefitinib. (June 2021) Authors: Escudero-Vilaplana, Vicente; Collado-Borrell, Roberto; Villanueva-Bueno, Cristina; Álvarez, Rosa; Herranz, Ana; Sanjurjo, María Journal: Journal of oncology pharmacy practice Issue: Volume 27:Number 4(2021) Page Start: 980 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain. Issue 2 (1st February 2021) Authors: Chamorro-de-Vega, Esther; Rodriguez-Gonzalez, Carmen-Guadalupe; Manrique-Rodríguez, Silvia; Lobato-Matilla, Elena; García-Moreno, Felix; Olmedo, Maria; Correa-Rocha, Rafael; Valerio, Maricela; Aldámiz-Echevarria, Teresa; Machado, Marina; Sancho-Gonzalez, Milagros; Lopez-Bernaldo-de-Quirós, Juan C... Journal: Expert review of clinical pharmacology Issue: Volume 14:Issue 2(2021) Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1. (31st December 2023) Authors: Escudero-Vilaplana, Vicente; Collado-Borrell, Roberto; De Castro, Javier; Insa, Amelia; Martínez, Alex; Fernández, Elena; Sullivan, Ivana; Flores, Andrés; Arrabal, Natalia; Carcedo, David; Manzaneque, Alba Journal: Journal of medical economics Issue: Volume 26:Number 1(2023) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Design of the functional requirements of a smartphone app for patients receiving oral antineoplastic agents: The e-OncoSalud® app. (January 2020) Authors: Collado-Borrell, Roberto; Escudero-Vilaplana, Vicente; Ribed, Almudena; Anglada-Martínez, Helena; Martín-Conde, Maite; Herranz-Alonso, Ana; Codina-Jané, Carlos; Sanjurjo-Sáez, María Journal: Journal of oncology pharmacy practice Issue: Volume 26:Number 1(2020) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Medication guide for the perioperative management of oral antineoplastic agents in cancer patients. Issue 1 (2nd January 2022) Authors: Villanueva-Bueno, Cristina; Escudero-Vilaplana, Vicente; Collado-Borrell, Roberto; Giménez-Manzorro, Álvaro; Ribed, Almudena; Marzal-Alfaro, Belén; Revuelta-Herrero, José Luis; Gonzalez-Haba, Eva; Herranz, Ana; Sanjurjo, Maria Journal: Expert opinion on drug safety Issue: Volume 21:Issue 1(2022) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents. (4th July 2020) Authors: Collado-Borrell, Roberto; Escudero-Vilaplana, Vicente; Ribed, Almudena; Jiménez, Rosa Romero; Peinado, Irene Iglesias; Herranz-Alonso, Ana; Sanjurjo-Sáez, María Journal: American journal of health-system pharmacy Issue: Volume 77:Number 17(2020) Page Start: 1393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Oral antineoplastic agents: assessment of safety and dose adjustments in clinical practice. Issue 9 (2nd September 2019) Authors: Escudero-Vilaplana, Vicente; Revuelta-Herrero, Jose Luis; Collado-Borrell, Roberto; Marzal-Alfaro, Belen; Gimenez-Manzorro, Alvaro; Herranz-Alonso, Ana; Sanjurjo-Saez, María Journal: Expert opinion on drug safety Issue: Volume 18:Issue 9(2019) Page Start: 861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Posology adjustments of oral antineoplastic agents for special populations: patients with renal impairment, hepatic impairment and hematologic toxicities. Issue 6 (3rd June 2018) Authors: González, Julieta; Quiroga, Matías; Escudero-Vilaplana, Vicente; Collado-Borrell, Roberto; Herranz-Alonso, Ana; Sanjurjo Sáez, María Journal: Expert opinion on drug safety Issue: Volume 17:Issue 6(2018) Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Possible heart failure caused by osimertinib in a lung cancer patient. (June 2023) Authors: Ruiz-Briones, Paula; Escudero-Vilaplana, Vicente; Collado-Borrell, Roberto; Vicente-Valor, Juan; Alvarez, Rosa; Villanueva-Bueno, Cristina; Narrillos-Moraza, Álvaro; Herranz, Ana; Sanjurjo, Maria Journal: Journal of oncology pharmacy practice Issue: Volume 29:Number 4(2023) Page Start: 1015 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Potential and real drug interactions in patients treated with abiraterone or enzalutamide in clinical practice. (2nd December 2021) Authors: Vicente-Valor, Juan; Escudero-Vilaplana, Vicente; Collado-Borrell, Roberto; Pérez-Ramírez, Sara; Villanueva-Bueno, Cristina; Narrillos-Moraza, Álvaro; García-Sánchez, Sebastián; Beamud-Cortés, Manel; Herranz, Ana; Sanjurjo, María Journal: Expert opinion on drug metabolism and toxicology Issue: Volume 17:Number 12(2021) Page Start: 1467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗